Swixx Biopharma's acquisition of 100% of the equity of Pharma Consulting Group
Arias, Fábrega and Fábrega had advised Swixx Biopharma in the acquisition of 100% of the equity of Pharma Consulting Group S.A. the holding company of Laboratorios Biopas S.A. and related group companies throughout Latin America.
This transaction marks Swixx Biopharma's strategic expansion into the Latin American market (including now Argentina, Brazil, Chile and Colombia), thereby consolidating its position as a leading intercontinental commercial platform in the biopharmaceutical industry.